Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for August 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Second batch of fake Lipitor discovered
MHRA discovers more fake Lipitor..(more)

 Recovery of healthcare PR highlights recruitment needs
Mood of optimism growing..(more)

 Acambis developing universal flu vaccine
Scientists fear pandemic outbreak..(more)

 Pfizer acquires antibody optimisation company
Pfizer buys California-based Bioren..(more)

 Global giant VNU acquires IMS Health for $7 billion
Acquisition to strengthen VNU's position in the US..(more)

 FDA approves Diovan for cardiovascular indication
FDA expands Diovan's heart failure labelling..(more)

 Quintiles acquires site management organisation Profiad
Quintiles building extensive partner site network..(more)

 NICE rejects calls to fast-track cancer treatment
NICE criticised by charity over Xeloda appraisal..(more)

 AstraZeneca's Arimidex receives boost from study
AstraZeneca's Arimidex receives boost..(more)

 New study says cancer risk from HRT only moderate
Study good news for HRT manufacturers..(more)

 Equity fund snaps up biotech Xenova for £25 million
Celtic looks to expand portfolio to £500 million..(more)

 Celebrex approved for new arthritis indication
Cardiovascular risk warnings added to label..(more)

 Home tests to be offered to beat bowel cancer
SHAs invited to bid to provide screening centres..(more)

 Animal rights attacks curbed by new legislation
ABPI reports sharp drop in attacks..(more)

 Teva's modest sales growth driven by MS treatment
Copaxone growth offsets flat performance..(more)

 DTC advertising to be tightened up
Voluntary Guiding Principles introduced..(more)

 AstraZeneca name McKillop's successor as sales rise
Nexium and Seroquel drive sales increase ..(more)

 Seretide helps GSK overcome production problems
Second quarter results above expectations..(more)

 Red Door bought by marketing services group
Creston to provide avenue for growth..(more)

 Financial failings undermine improvements in NHS
Total overspend of £500 million..(more)

 New drug-resistant HIV treatment recommended
EMEA recommends Aptivus for approval..(more)

 Schering-Plough's new anti-fungal gains EMEA approval
Schering-Plough strengthens anti-infectives portfolio..(more)

 PCT mergers and commissioning changes to be decided in 2006
SHA reconfiguration deadline 2007..(more)

 Pfizer demands action after counterfeit Lipitor recovered in UK
MHRA discovers counterfeit batch..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.